Drug comparisons
Canagliflozin vs Insulin Degludec
Canagliflozin (Invokana) vs Insulin Degludec (Tresiba): Oral SGLT2 inhibitor vs long-acting insulin. Compare uses, efficacy, side effects for type 2 diabetes.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 2 diabetes patients not at goal on orals who are considering an SGLT2 inhibitor versus starting basal insulin.
Bottom line
Canagliflozin is often preferable for oral convenience and added benefits in type 2 diabetes, whereas Insulin Degludec is essential when insulin replacement is required.
All medication comparisons